Securian Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,835
| Closed | -$942K | – | 944 |
|
|
2022
Q3 | $942K | Buy |
3,835
+100
| +3% | +$24.6K | 0.03% | 456 |
|
|
2022
Q2 | $924K | Sell |
3,735
-100
| -3% | -$24.7K | 0.02% | 530 |
|
|
2022
Q1 | $1.27M | Hold |
3,835
| – | – | 0.02% | 503 |
|
|
2021
Q4 | $1.38M | Sell |
3,835
-64
| -2% | -$23K | 0.03% | 496 |
|
|
2021
Q3 | $1.27M | Sell |
3,899
-100
| -3% | -$32.5K | 0.03% | 498 |
|
|
2021
Q2 | $1.25M | Sell |
3,999
-100
| -2% | -$31.2K | 0.03% | 508 |
|
|
2021
Q1 | $1.31M | Hold |
4,099
| – | – | 0.03% | 486 |
|
|
2020
Q4 | $1.33M | Sell |
4,099
-50
| -1% | -$16.2K | 0.03% | 473 |
|
|
2020
Q3 | $1.15M | Hold |
4,149
| – | – | 0.03% | 479 |
|
|
2020
Q2 | $1M | Sell |
4,149
-270
| -6% | -$65.2K | 0.03% | 498 |
|
|
2020
Q1 | $641K | Sell |
4,419
-100
| -2% | -$14.5K | 0.02% | 562 |
|
|
2019
Q4 | $771K | Sell |
4,519
-281
| -6% | -$47.9K | 0.02% | 635 |
|
|
2019
Q3 | $854K | Buy |
4,800
+100
| +2% | +$17.8K | 0.02% | 600 |
|
|
2019
Q2 | $1.22M | Hold |
4,700
| – | – | 0.03% | 495 |
|
|
2019
Q1 | $1.34M | Hold |
4,700
| – | – | 0.03% | 455 |
|
|
2018
Q4 | $1.53M | Hold |
4,700
| – | – | 0.04% | 381 |
|
|
2018
Q3 | $2.11M | Buy |
4,700
+300
| +7% | +$135K | 0.05% | 331 |
|
|
2018
Q2 | $1.8M | Sell |
4,400
-773
| -15% | -$316K | 0.04% | 372 |
|
|
2018
Q1 | $1.51M | Hold |
5,173
| – | – | 0.04% | 414 |
|
|
2017
Q4 | $969K | Sell |
5,173
-125
| -2% | -$23.4K | 0.02% | 580 |
|
|
2017
Q3 | $893K | Buy |
5,298
+114
| +2% | +$19.2K | 0.02% | 564 |
|
|
2017
Q2 | $743K | Hold |
5,184
| – | – | 0.02% | 611 |
|
|
2017
Q1 | $649K | Buy |
5,184
+170
| +3% | +$21.3K | 0.02% | 658 |
|
|
2016
Q4 | $565K | Buy |
5,014
+143
| +3% | +$16.1K | 0.02% | 696 |
|
|
2016
Q3 | $626K | Buy |
4,871
+110
| +2% | +$14.1K | 0.02% | 636 |
|
|
2016
Q2 | $520K | Sell |
4,761
-499
| -9% | -$54.5K | 0.01% | 679 |
|
|
2016
Q1 | $499K | Buy |
+5,260
| New | +$499K | 0.01% | 711 |
|